BlackRock Inc. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 39 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$4,223,000
+43.0%
3,205,000
+42.1%
0.00%
Q1 2022$2,954,000
-10.8%
2,255,000
-15.1%
0.00%
Q4 2021$3,310,000
-6.0%
2,655,0000.0%0.00%
Q3 2021$3,520,000
+34.7%
2,655,000
+35.8%
0.00%
Q2 2021$2,614,000
-21.0%
1,955,000
-20.5%
0.00%
Q1 2021$3,307,000
-10.4%
2,460,000
-8.0%
0.00%
Q4 2020$3,691,000
+29.4%
2,675,000
+28.9%
0.00%
Q3 2020$2,853,000
-8.5%
2,075,000
+10.7%
0.00%
Q2 2020$3,118,000
+49.8%
1,875,000
+15.4%
0.00%
Q1 2020$2,082,000
-28.4%
1,625,000
-14.5%
0.00%
Q4 2019$2,909,000
+41.6%
1,900,000
+26.7%
0.00%
Q3 2019$2,054,000
+18.2%
1,500,000
+13.2%
0.00%
Q2 2019$1,738,000
-3.0%
1,325,0000.0%0.00%
Q1 2019$1,791,000
+20.0%
1,325,000
+6.0%
0.00%
Q4 2018$1,492,000
-12.5%
1,250,000
+25.0%
0.00%
Q3 2018$1,705,000
+68.8%
1,000,000
+42.9%
0.00%
Q2 2018$1,010,000700,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders